Expression of vascular endothelial growth factor in human gastric carcinomas

Pathology International

Volumn 48, Issue 7, 1998, Pages 499-506

  Yamamoto, Soichiro ^a   Yasui, Wataru ^a   Kitadai, Yasuhiko ^a   Yokozaki, Hiroshi ^a   Haruma, Ken ^a   Kajiyama, Goro ^a   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric carcinoma; Vascular endothelial growth factor; Vessel count

Indexed keywords

VASCULOTROPIN;

ADENOCARCINOMA; ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STOMACH CARCINOMA; STOMACH MUCOSA; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

EID: 0031826646     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03940.x     Document Type: Article

References (45)

1. Folkman M. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 1971; 286: 1182-1186.
2. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61.
3. Weidner N, Folkman J, Pozza F et al. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast cancer. J. Natl Cancer Inst. 1992; 84: 1875-1887.
4. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol. 1995; 147: 9-19.
5. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am. J. Pathol. 1994; 145: 510-514.
6. Tanigawa N, Amaya H, Matsumura M et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res. 1996; 56: 2671-2676.
7. Fidler IJ, Ellis LM. The implications of angiogenesis for biology and therapy of cancer metastasis. Cell 1994; 79: 185-188.
8. Koch AE, Polverini PJ, Kunkel SL et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-1801.
9. Tsai J, Goldman CK, Gillespie GY. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB, and bFGF. J. Neurosurg. 1995; 82: 864-873.
10. Berse B, Brown L, Van De Water L, Dvorak H, Senger DR. Vascular permeability gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 1992; 3: 211-220.
11. de Vries C, Escobido JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-991.
12. Leung DW, Cachianes G, Kuang WJ, Goeddele DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
13. Tischer E, Mitchell R, Hartman T et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 1991; 266: 11 947-11 954.
14. Houch KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family, identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 1991; 5: 1806-1814.
15. Mukhopadhyay D, Tsiokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP. Hypoxia induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995; 375: 577-581.
16. Rak J, Mitsuhashi Y, Bakyo L et al. Mutant ras oncogenes up-regulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res. 1995; 55: 4575-4580.
17. Grugel S, Finkenzeller G, Weindel K, Barleon B, Marme D. Both v-H-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 1995; 270: 25 915-25 919.
18. Dolecki GJ, Connolly DT. Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. Biochem. Biophys. Res. Commun. 1991; 180: 572-578.
19. Cohen T, Nahart D, Cerem LW, Neufeld G, Levi B-Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 1996; 271: 736-741.
20. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985; 313: 745-747.
21. Sporn MB, Roberts AB. Peptide growth factors are multifunctional. Nature 1988; 332: 217-218.
22. Tahara E. Growth factors and oncogenes in human gastrointestinal carcinomas. J. Cancer Res. Clin. Oncol. 1990; 116: 121-131.
23. Tanimoto H, Yoshida K, Yokozaki H et al. Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch. B Cell Pathol. 1991; 61: 263-267.
24. Ochiai A, Yasui W, Tahara E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res. 1985; 76: 1064-1071.
25. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma, 1st English edn. Kanehara, Tokyo, 1995.
26. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M, Tahara E. Expression of TGF-β and procollagen type I and type III in human gastric carcinomas. Int. J. Cancer 1989; 44: 394-398.
27. Kitadai Y, Bucana CD, Ellis LM, Anzai H, Tahara E, Fidler IJ. In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Am. J. Pathol. 1995; 147: 1238-1247.
28. WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: Relationship with p53 status and proliferative activity. J. Pathol. 1996; 180: 122-128.
29. Yoshida K, Takanashi A, Kyo E et al. Epidermal growth factor induces the expression of its receptor gene in human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res. 1989; 80: 743-746.
30. Yoshida K, Kyo E, Tsujino T, Niimoto M, Tahara E. Expression of epidermal growth factor, transforming growth factor-α and their receptor genes in human gastric carcinomas: Implication for autocrine growth. Jpn J. Cancer Res. 1990; 81: 43-51.
31. Ito R, Kitadai Y, Kyo E et al. Interleukin 1a acts as an autocrine growth stimulator for human gastric carcinoma cells. Cancer Res. 1993; 53: 4102-4106.
32. kip1 in a human gastric carcinoma cell line. Cell Growth & Differ. 1997; 8: 47-52.
33. Sidky YA, Borden EC. Inhibition of angiogenesis by interferons: Effect on tumor and lymphocyte induced vascular responses. Cancer Res. 1987; 47: 5155-5561.
34. Dinarello CA. Biology of interleukin 1. FASEB J. 1988; 2: 108-115.
35. Keise A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase-C induction of vascular endothelial growth factor expression. Oncogene 1994; 9: 963-969.
36. Matter R, Yokozaki H, Yasui W, Ito H, Tahara E. p53 gene mutations in gastric cancer cell lines. Oncol. (Life Sci. Adv.), 1992; 11: 7-12.
37. Takekawa Y, Sawada T. Vascular endothelial growth factor and neovascularization in astrocytic tumors. Pathol. Int. 1998; 48: 109-114.
38. Ranzani GN, Renault B, Pellegata NS et al. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum. Genet. 1993; 92: 244-249.
39. Nishi M, Tamura T. Clinical study of stomach cancer with hepatic metastasis. Jpn J. Cancer Clin. 1962; 8: 422-433 (in Japanese).
40. Duarte I, Llanos O. Patterns of metastasis in intestinal and diffuse types of carcinoma of the stomach. Hum. Pathol. 1981; 12: 237-242.
41. Maeda K, Chung Y-S, Takatsuka S et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J. Clin. Oncol. 1995; 13: 477-481.
42. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res. 1996; 56: 2013-2016.
43. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J. Cancer Res. 1994; 85: 1045-1049.
44. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin. Cancer Res. 1996; 2: 1679-1684.
45. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 1995; 55: 510-513.